Filing Flows › Assembly Biosciences (ASMB) › R&D spending
Assembly Biosciences (ASMB) R&D spending by quarter
Assembly Biosciences' R&D spending was $14.9M in Q2 2026 (second quarter 2026), +0.1% from Q1 2026. Over the last 6 quarters it ranged from $14.3M (Q4 2024) to $16.6M (Q3 2025).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $14.9M | +0.1% | -7% |
| Q1 2026 | $14.9M | -10% | +0.3% |
| Q3 2025 | $16.6M | +3% | — |
| Q2 2025 | $16.1M | +9% | — |
| Q1 2025 | $14.9M | +4% | — |
| Q4 2024 | $14.3M | — | — |
Q2 2026 at a glance
Assembly Biosciences, Q2 2026: revenue $13.4M (+39% year over year), operating margin -47.4%, net loss $3.9M, operating cash flow −$15.5M. The chart follows the revenue to costs, profit and cash.
Questions
What is Assembly Biosciences' R&D spending?
Assembly Biosciences' R&D spending was $14.9M in Q2 2026 (second quarter 2026), +0.1% from Q1 2026.
How has Assembly Biosciences' R&D spending changed?
Over the last 6 quarters it ranged from $14.3M (Q4 2024) to $16.6M (Q3 2025).